Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Melanoma Clinical Trials Resources presented on Clinical Trials Search isn't designed to be a substitute for qualified healthcare advice, visits or professional assistance by using a real medical doctor. We aren't mDs. Always consult your physician about Melanoma conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Melanoma Clinical research trials and Melanoma health trials happen in a lot of of localities across the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new drugs. The function of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to discover treatments for all kinds of circumstances, including Melanoma. Melanoma Clinical Trials and other clinical trials allow volunteers to undergo health treatment alternatives before they are available to the masses. Most times the human subjects receive treatment for free of charge, and occasionally they are paid for their time. Occasionally there is a cost for a Melanoma clinical trial. Test subjects typically recieve the most expert healthcare available for their Melanoma affliction. Hazards are a reality, however, and may include additional or frequent dr. trips, healthcare dangers (potentially life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigid guidelines to protect clinical trials subjects.

Home > Clinical Trials by Conditions > "M" Clinical Trial Conditions > Melanoma Clinical Trials

Melanoma Clinical Trials



A Phase I Study of gp100 Human Melanoma Peptide Vaccine with Incomplete Freund's Adjuvant
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Intralesional Administration of an Adenovirus Vector Expressing the HSV-1 Thymidine Kinase Gene (AdV.RSV-TK) in Combination with Escalating Doses of Ganciclovir in Patients with Cutaneous Metastatic Malignant Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase I Study of Oral COL-3 (NSC-683551), a Matrix Metalloproteinase Inhibitor, in Patients with Refractory Metastatic Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase II Protocol of Flt3 Ligand in Patients with Metastatic Melanoma and Renal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients with Ocular Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Phase II study of PI-88 in Patients with Advanced Melanoma
Condition: progen_industries_limited_clinical_trials.html
Progen Industries Limited

A Phase III Multi-Institutional Randomized Study of Immunization with the gp100: 209-217 (210M) Peptide Followed by High Dose IL-2 vs. High Dose IL-2 Alone in Patients with Metastatic Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion with Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients with Locally Advanced Extremity Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

ADI-PEG in Patients With Metastatic Melanoma
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Biological Therapy in Treating Children With Refractory or Recurrent Neuroblastoma or Other Tumors
Condition: childrens_oncology_group_clinical_trials.html
Children's Oncology Group

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Comparison of Two Kinds of Dendritic Cell Immunizations in Treating Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Comparison Study of MDX-010 (CTLA-4) Alone and Combined with DTIC in the Treatment of Metastatic Melanoma
Condition: medarex_clinical_trials.html
Medarex

CPG 7909 in Melanoma
Condition: coley_pharmaceutical_group_clinical_trials.html
Coley Pharmaceutical Group

CTLA-4 Antibody (MDX-010) Plus Interleukin-2 to Treat Advanced Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Decitabine in Treating Patients With Advanced Solid Tumors
Condition: university_of_southern_california_clinical_trials.html
University of Southern California

EPO906 Therapy in Patients with Advanced Melanoma
Condition: novartis_pharmaceuticals_clinical_trials.html
Novartis Pharmaceuticals

Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma
Condition: medimmune_inc_clinical_trials.html
MedImmune, Inc.

Flt3L and CD40L to Treat Metastatic Melanoma and Kidney Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

gp100 and MART-1 Peptide Vaccine for Metastatic Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

gp100 and MART-1 Peptide Vaccine for Metastatic Ocular Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

gp100 and MDX-010 Vaccination for Stage IV Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

IL-2 Gene Therapy for Metastatic Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of HLA-A201 Patients with Metastatic Melanoma Using a Combination of Immunodominant Peptides from Three Melanoma Antigens, MART-1, GP100 and Tyrosinase
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using DNA Encoding the GP100 Melanoma Antigen
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using Immunodominant Peptides from the Tyrosinase Protein, Tyrosinase Related Protein-1 (TRP1), or GP100 Protein
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using MART-1 and GP100 Peptides Modified to Increase Binding to HLA-0201
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using Recombinant Fowlpox and Vaccinia Viruses Encoding the Tyrosinase Antigen
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using Recombinant Fowlpox Virus Encoding a gp100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunization of Patients with Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
Condition: centro_oncologico_de_excelencia_clinical_trials.html
Centro Oncologico de Excelencia

Immunotherapy with Autologous Dexosomes for Patients with Stage IV Melanoma
Condition: anosys_clinical_trials.html
Anosys

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Magnetic-Targeted Doxorubicin in Treating Patients with Cancer Metastatic to the Liver
Condition: ferx_clinical_trials.html
FeRx

Microarray Analysis for Human Genetic Disease
Condition: national_human_genome_research_institute_nhgri_clinical_trials.html
National Human Genome Research Institute (NHGRI)

Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer
Condition: danafarberharvard_cancer_center_clinical_trials.html
Dana-Farber/Harvard Cancer Center

Novel Adjuvants for Peptide-Based Melanoma Vaccines
Condition: fda_office_of_orphan_products_development_clinical_trials.html
FDA Office of Orphan Products Development

Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Phase I Study in Patients with Metastatic Melanoma of Immunization with Dendritic Cells Presenting Epitopes Derived from the Melanoma Associated Antigen MART-1 and gp100
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Phase I Trial in Patients with Metastatic Melanoma of Immunization with a Recombinant Fowlpox Virus Encoding the gp100 Melanoma Antigen
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Phase II Trial of Allovectin-7® for Metastatic Melanoma
Condition: vical_clinical_trials.html
Vical

Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Stem Cell Transplant for Malignant Melanoma
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)

Study of ILX651 in Patients with Inoperable Locally Advanced or Metastatic Melanoma
Condition: ilex_products_clinical_trials.html
ILEX Products

Study of Inhaled Doxorubicin (Adriamycin) to Treat Advanced Lung Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)

Study of Karenitecin (BNP1350) to treat Malignant Melanoma
Condition: bionumerik_pharmaceuticals_inc_clinical_trials.html
BioNumerik Pharmaceuticals, Inc.

Study of Talabostat and Cisplatin in Advanced Melanoma
Condition: point_therapeutics_clinical_trials.html
Point Therapeutics

Study of Talabostat in Advanced Melanoma
Condition: point_therapeutics_clinical_trials.html
Point Therapeutics

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects with Metastatic Malignant Melanoma.
Condition: celgene_corporation_clinical_trials.html
Celgene Corporation



Melanoma Clinical Trials

Modify your Search

Melanoma Clinical Trials by State:

Alabama
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
Ohio
Oklahoma
Oregon
Pennsylvania
South Carolina
South Dakota
Tennessee
Texas
Utah
Virginia
Washington
Wisconsin

Other "M" Clinical Trials Conditions:

Macular Degeneration
Macular Edema
Macular Edema, Cystoid
Maculopathies, Age-Related
Maculopathy, Age-Related
Magnetic Resonance Imaging
Major Depression
Major Depressive Disorder
Malaria
Male Breast Cancer
Male Infertility
Male Reproductive Cancer
Malignant Astrocytoma
Malignant Glioma
Malignant Gliomas
Malignant Melanoma
Malignant Meningeal Neoplasms
Malignant Mesothelioma
Malignant Metastatic Melanoma
Malignant Neoplasms, Brain
Malignant Pleural Effusion
Malocclusion
Mandibular Advancement
Manic Disorder
Manipulation, Spinal
Mannosidosis
Mansonelliasis
Mantle Cell Lymphoma
Marasmus
Marburg's Variant Of Multiple Sclerosis
Marfan Syndrome
Marijuana Abuse
Mastocytosis
Mccune Albright Syndrome
Measles
Meconium Aspiration
Mediastinal Cancer
Medullary Thyroid Cancer
Medulloblastoma
Melancholia
Melanoma
Melas Syndrome
Membranous Glomerulonephritis
Memory Disorder
Memory Disorders
Memory, Short-Term
Meningeal Cancer
Meningeal Neoplasm
Meningeal Neoplasms
Meningioma
Meningitis
Meningitis, Cryptococcal
Meningomyelocele
Menopausal Complaints
Menopausal Symptoms
Menopause
Menstruation Disorders
Mental Disorder
Mental Disorder Diagnosed In Childhood
Mental Disorders
Mental Disorders Diagnosed In Childhood
Mental Health
Mental Health Services
Mental Retardation
Mercury Poisoning
Merkel Cell Carcinoma
Mesothelioma
Metabolic Disease
Metabolic Syndrome X
Metabolism
Metabolism, Inborn Errors
Metachromatic Leukodystrophy
Metastases, Neoplasm
Metastasis
Metastatic Breast Cancer
Metastatic Cancer
Metastatic Childhood Soft Tissue Sarcoma
Metastatic Gastrointestinal Carcinoid Tumor
Metastatic Melanoma
Metastatic Osteosarcoma
Metastatic Renal Cell Cancer
Metastatic Squamous Neck Cancer With Occult Primary
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
Metastatic Transitional Cell Cancer Of The Renal Pelvis And Ureter
Metastatic Tumors Of The Ewing's Family
Methadone
Methamphetamine
Methionine Adenosyltransferase Deficiency
Microcephaly
Migraine
Migraine Headache
Mild Cognitive Impairment
Miscarriages
Miscellaneous Islet Cell Cancer
Mitochondrial Diseases
Mitochondrial Myopathy
Mitral Valve Insufficiency
Mitral Valve Stenosis
Mixed Adenocarcinoma Of The Stomach
Mixed Cell Leukemia
Mixed Gliomas
Mixed Oligoastrocytoma
Mondini Dysplasia
Monoclonal Gammopathy Of Undetermined Significance
Mood Disorder
Mood Disorders
Mood Management
Mood Tolerance
Morphine Dependence
Motor Deficits
Motor Neuron Disease
Mouth Cancer
Mouth Disease
Mouth Diseases
Mouth Neoplasms
Movement Disorder
Movement Disorders
Mucinous Adenocarcinoma Of The Colon
Mucocutaneous Lymph Node Syndrome
Mucolipidosis Type Iv
Mucopolysaccharidosis I
Mucopolysaccharidosis Ii
Mucopolysaccharidosis Vi
Multiple Abnormalies
Multiple Endocrine Neoplasia
Multiple Myeloma
Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Multiple System Atrophy
Muscle Atrophy
Muscle Cancer
Muscle Cramp
Muscle Hypotonia
Muscle Rigidity
Muscle Spasticity
Muscle Strength
Muscle Weakness
Muscular Atrophy
Muscular Disease
Muscular Dystrophies
Muscular Dystrophy
Muscular Dystrophy, Duchenne
Muscular Dystrophy, Facioscapulohumeral
Musculoskeletal Cancer
Musculoskeletal Diseases
Musculoskeletal Physiology
Musculoskeletal Tumors
Myasthenia Gravis
Mycobacterium Avium-Intracellulare Infection
Mycobacterium Infection
Mycobacterium Infections
Mycobacterium Infections, Atypical
Mycobacterium Tuberculosis
Mycoplasma Fermentans
Mycoses
Mycosis Fungoides
Mycosis Fungoides And Sezary Syndrome
Mycosis Fungoides/sezary Syndrome
Myelitis
Myelodysplastic And Myeloproliferative Disease
Myelodysplastic And Myeloproliferative Diseases
Myelodysplastic Disorders
Myelodysplastic Syndrome
Myelodysplastic Syndromes
Myelodysplastic/myeloproliferative Disease, Unclassifiable
Myelofibrosis
Myelogenous Leukemia, Chronic
Myelogenous Leukemia, Chronic, Chronic Phase
Myeloid Leukemia
Myeloid Lymphoma
Myeloma
Myeloproliferative Disorder
Myeloproliferative Disorders
Myocardial Disease
Myocardial Diseases
Myocardial Infarction
Myocardial Injury
Myocardial Ischemia
Myocarditis
Myoclonic Epilepsy
Myoclonus
Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint
Myopia
Myositis
Myotonic Dystrophy


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103